...
首页> 外文期刊>Journal of applied clinical medical physics / >Volumetric‐modulated arc therapy and intensity‐modulated radiation therapy treatment planning for prostate cancer with flattened beam and flattening filter free linear accelerators
【24h】

Volumetric‐modulated arc therapy and intensity‐modulated radiation therapy treatment planning for prostate cancer with flattened beam and flattening filter free linear accelerators

机译:带有扁平光束和扁平无滤波器直线加速器的前列腺癌的容积调制弧光疗法和强度调制放射疗法治疗计划

获取原文
           

摘要

This study on patients with localized prostate cancer was set up to investigate valuable differences using flattened beam (FB) and flattening filter free (FFF) mode in the application of intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT). For ten patients, four different plans were calculated with Oncentra planning system of Elekta, using Synergy machines: IMRT and VMAT, with and without flattening filter. Homogeneity and conformity indexes, dose to the organs at risk, and measurements of peripheral dose and dosimetric plan verification including record of the delivery times were analyzed and statistically evaluated. The indexes for homogeneity and conformity (CTV and PTV) are either advantageous or not significantly different for FFF compared to FB with one minor exception. Regarding the doses to the organs at risk and the measured peripheral dose, equivalent or lower doses were delivered for FFF than with FB. Furthermore, the delivery times were significantly shorter for FFF. VMAT compared to IMRT reveals benefits or at least equivalent values. VMAT-FFF combines the most advantageous plan quality parameters with the shortest delivery times and reduced peripheral dose and is therefore recommended for the given equipment and cancer localization.
机译:这项针对局限性前列腺癌患者的研究旨在通过在强度调制放射疗法(IMRT)和体积调制弧光疗法(VMAT)中使用扁平化光束(FB)和扁平化无滤光片(FFF)模式研究有价值的差异。对于十名患者,使用Synergy机器,通过Elekta的Oncentra规划系统计算了四个不同的计划:IMRT和VMAT,带有和不带有扁平滤波器。对同质性和合格性指数,对处于危险中的器官的剂量以及外围剂量的测量和剂量计验证(包括分娩时间记录)进行了分析和统计评估。与FB相比,FFF的同质性和一致性指标(CTV和PTV)具有优势或无显着差异,只有一个小小的例外。关于有风险的器官的剂量和测得的外周剂量,与FB相比,FFF的等效剂量或更低剂量。此外,FFF的交货时间明显缩短。与IMRT相比,VMAT可以显示出好处或至少具有同等价值。 VMAT-FFF将最有利的计划质量参数与最短的交货时间和减少的外周剂量相结合,因此推荐用于给定的设备和癌症定位。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号